Alain M. Gardier

Chatenay-sur-seine, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 75 publications

Fundamental and clinical pharmacology for a new psychiatry.

Fundamental and clinical pharmacology for a new psychiatry.

Journal: Fundamental & clinical pharmacology

Published: April 23, 2025

Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.

Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.

Journal: Fundamental & clinical pharmacology

Published: February 28, 2025

Chronic, combinatorial targeting of NMDARs and 5-HT4Rs exerts extended behavioral effects against stress-induced perseverative behavior and hyponeophagia.

Chronic, combinatorial targeting of NMDARs and 5-HT4Rs exerts extended behavioral effects against stress-induced perseverative behavior and hyponeophagia.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Published: January 14, 2025

A Tale of Two Receptors: Simultaneous Targeting of NMDA Receptors and 5-HT4 Receptors Exerts Additional Effects Against Stress.

A Tale of Two Receptors: Simultaneous Targeting of NMDA Receptors and 5-HT4 Receptors Exerts Additional Effects Against Stress.

Journal: Biological psychiatry

Published: November 22, 2024

Ketamine metabolism via hepatic CYP450 isoforms contributes to its sustained antidepressant actions.

Ketamine metabolism via hepatic CYP450 isoforms contributes to its sustained antidepressant actions.

Journal: Neuropharmacology

Published: April 02, 2024

A tale of two receptors: simultaneous targeting of NMDARs and 5-HT 4 Rs exerts additive effects against stress.

A tale of two receptors: simultaneous targeting of NMDARs and 5-HT 4 Rs exerts additive effects against stress.

Journal: bioRxiv : the preprint server for biology

Published: October 09, 2023

Ketamine and suicidal behavior: Contribution of animal models of aggression-impulsivity to understanding its mechanism of action

Ketamine and suicidal behavior: Contribution of animal models of aggression-impulsivity to understanding its mechanism of action

Journal: Annales pharmaceutiques francaises

Published: June 19, 2023

Ketamine: a neuropsychotropic drug with an innovative mechanism of action

Ketamine: a neuropsychotropic drug with an innovative mechanism of action

Journal: Biologie aujourd'hui

Published: April 22, 2023

Pharmacological Mechanism of Ketamine in Suicidal Behavior Based on Animal Models of Aggressiveness and Impulsivity: A Narrative Review.

Pharmacological Mechanism of Ketamine in Suicidal Behavior Based on Animal Models of Aggressiveness and Impulsivity: A Narrative Review.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 06, 2023

Intrahippocampal injection of a selective blocker of NMDA receptors containing the GluN2B subunit, Ro25-6981, increases glutamate neurotransmission and induces antidepressant-like effects.

Intrahippocampal injection of a selective blocker of NMDA receptors containing the GluN2B subunit, Ro25-6981, increases glutamate neurotransmission and induces antidepressant-like effects.

Journal: Fundamental & clinical pharmacology

Published: November 23, 2022

A complex relation between levels of adult hippocampal neurogenesis and expression of the immature neuron marker doublecortin.

A complex relation between levels of adult hippocampal neurogenesis and expression of the immature neuron marker doublecortin.

Journal: Hippocampus

Published: August 25, 2022

Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review.

Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review.

Journal: Therapeutic advances in psychopharmacology

Published: August 01, 2022

Showing 1-12 of 75

Last Updated: 09/26/2026